Chronic Kidney Disease Epidemiology Forecast 2026-2035

Read more about this report - Request a Free Sample

Chronic Kidney Disease Epidemiology Forecast Report Coverage

Expert Market Research's “Chronic Kidney Disease Epidemiology Forecast Report 2026-2035” offers comprehensive information on the prevalence and demographics of chronic kidney disease. It projects the future incidence and prevalence rates of chronic kidney disease cases across various populations. The study covers age, gender, and type as major determinants of the chronic kidney disease population. The report highlights patterns in the prevalence of chronic kidney disease over time and projects future trends based on multiple variables.

Chronic Kidney Disease Understanding: Disease Overview

Chronic kidney disease (also known as chronic renal failure) is characterized by progressive and irreversible loss of kidney function over months or years, defined by reduced glomerular filtration rate (GFR) or markers of kidney damage. It is categorized into five stages based on GFR, ranging from mild dysfunction to end-stage renal disease. Major causes include diabetes mellitus, hypertension, and glomerulonephritis. It increases the risk of cardiovascular events, anemia, and bone disorders, and represents a major global health burden requiring early detection and long-term management.

Chronic Kidney Disease Epidemiology Perspective

The chronic kidney disease epidemiology division offers information on the patient pool from history to the present, as well as the projected trend for each of the 8 major markets. Expert Market Research provides both current and predicted trends for the chronic kidney disease epidemiology scenario by examining a wide range of studies. Additionally, the report covers the diagnosed patient pool for chronic kidney disease and their trends. The chronic kidney disease detailed epidemiology segmentation is broken down into specific categories, such as total prevalent cases in males and females, and total diagnosed cases across different age groups and patient pools.

• CKD was the 10th leading cause of death worldwide in 2019 and has climbed to 8th position in 2023, surpassing conditions such as breast cancer and tuberculosis. It accounts for approximately 1.4 million deaths annually (as per WHO estimates for 2023).
• According to the Global Burden of Disease (GBD) 2023 study, CKD affects approximately 850 million people worldwide, making it one of the most prevalent non-communicable diseases globally.
• Highest prevalence is observed in Central Latin America (14.5%), Sub-Saharan Africa (13.7%), and South Asia (11.9%). Lowest prevalence is seen in high-income Asian Pacific countries (~7%) and Western Europe (~6.8%).
• Countries with high diabetes and hypertension rates, such as India, China, Mexico, and the United States, account for a large proportion of global CKD cases.
• Globally, men bear a greater burden of CKD compared to women. However, the gender gap is narrower in developed regions. The global age-standardized mortality rate for CKD is 18.5 per 100,000 population, with higher rates in men than women.
• In 2021, there were 36,754 new cases of CKD due to hypertension among adolescents and young adults globally, with an age-standardized incidence rate of 0.91 per 100,000 population.

Read more about this report - Request a Free Sample

Country-wise Chronic Kidney Disease Epidemiology Segment

The chronic kidney disease epidemiology data and findings for the United States, Germany, Spain, Italy, France, the United Kingdom, Japan, and India are also provided in the epidemiology section.

In the United States, chronic kidney disease (CKD) affects approximately 35.5 million adults (14%), with prevalence rising sharply with age: 6% among 18-44 years, 12% among 45-64 years, and 34% among those 65 and older. Gender differences exist, with 14% of women and 12% of men affected, and racial disparities are notable: 20% of non-Hispanic Black adults, 12% of non-Hispanic White adults, and 14% of Hispanic adults have CKD. Early detection, preventive care, and equitable access to treatment are crucial for reducing CKD-related morbidity.

India is estimated to have over 120 million people living with CKD, making it one of the countries with the largest absolute burden globally. The Indian CKD Registry reports a prevalence of 17.2% among adults, higher than the global average. Diabetic nephropathy accounts for ~31% of cases, while hypertension contributes to ~13%. Rural and peri-urban areas are disproportionately affected due to limited access to early detection, nephrology services, and renal replacement therapy.

Chronic Kidney Disease: Treatment Overview

CKD treatment aims to slow progression, manage complications, and preserve renal function. Core strategies include strict control of blood pressure, glycemia, and lipids using ACE inhibitors, ARBs, or SGLT2 inhibitors. Dietary modifications, such as reduced sodium and protein intake, help limit renal strain. Anemia and bone-mineral disorders are managed with erythropoiesis-stimulating agents and phosphate binders. In advanced stages, renal replacement therapy via dialysis or kidney transplantation becomes necessary. Patient education and lifestyle adjustments play key roles in improving prognosis.

Key Questions Answered

• What are the key findings of chronic kidney disease epidemiology in the 8 major markets?
• What will be the total number of patients with chronic kidney disease across the 8 major markets during the forecast period?
• What was the country-wise chronic kidney disease epidemiology scenario in the 8 major markets in the historical period?
• Which country will have the highest number of cases of chronic kidney disease during the forecast period of 2026-2035?
• Which key factors would influence the shift in the patient population of chronic kidney disease during the forecast period of 2026-2035?
• What are the currently available treatments for chronic kidney disease?
• What are the disease risks, signs, symptoms, and unmet needs of chronic kidney disease?

Scope of the Chronic Kidney Disease Epidemiology Report

• The report covers a detailed analysis of signs and symptoms, causes, risk factors, pathophysiology, diagnosis, treatment options, and classification/types of chronic kidney disease based on several factors.
• Chronic Kidney Disease Epidemiology Forecast Report covers data for the eight major markets (the US, France, Germany, Italy, Spain, the UK, Japan, and India).
• The chronic kidney disease report helps to identify the patient population, and the unmet needs are highlighted along with an assessment of the disease's risk and burden.

Related Reports

Polycystic Kidney Disease Drug Pipeline Analysis

Chronic Kidney Disease Drug Pipeline Analysis

Polycystic Kidney Disease Drugs Market